Winx Overview

  • Founded
  • 2007

  • Status
  • Out of Business

  • Employees
  • 28

  • Latest Deal Type
  • Out of Business

Winx General Information


Developer of a sleep therapy systems designed to help users breathe naturally while sleeping in any position. The company's systems deliver a light vacuum through a soft, flexible mouthpiece that fits comfortably in the mouth and keeps the airway open during sleep by gently drawing the soft palate forward and stabilizing the tongue, enabling sleep apnea patients to sleep peacefully and eliminate the annoying noises.

Contact Information

Formerly Known As
Ownership Status
Out of Business
Financing Status
Formerly VC-backed
Primary Industry
Therapeutic Devices
Primary Office
  • 900 Chesapeake Drive
  • Redwood City, CA 94063
  • United States
+1 (650) 000-0000

Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Winx Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
7. Out of Business 01-Feb-2018 000.00 Completed Out of Business
6. Later Stage VC (Series AA) 16-Mar-2016 000.00 000.00 000.00 Completed Generating Revenue
5. Later Stage VC (Series C2) 01-Apr-2013 00.00 000.00 00000 Completed Startup
4. Grant 18-May-2012 00000 000.00 Completed Startup
3. Later Stage VC (Series C) 01-Jan-2010 000.00 000.00 00000 Completed Startup
2. Early Stage VC (Series B) 01-Jan-2009 $12.9M $17.3M 000.00 Completed Startup
1. Early Stage VC (Series A) 01-Jan-2007 $4.42M $4.42M 00.00 Completed Startup
To view Winx’s complete valuation and funding history, request access »

Winx Cap Table

Stock # of Shares
Par Value Dividend Rate ($) Original
Issue Price
Liquidation Liquidation
Pref. Multiple
Conversion Price % Owned
Series AA 00,000,000 00.000000 00.00 00.00 00.00 00 00.00 00.000
Series D 00,000 00.000000 00.00 000.00 000.00 00 000.00 0.000
Series C2 00,000 00.000000 00.00 0000.00 0000.00 00 0000.00 0.000
Series C1 00,000 00.000000 00.00 0000.00 0000.00 00 0000.00 0.000
Series B 82,996 $0.001000 $0.12 $155.6 $77.8 0x $155.6 0.19%
Series A 44,760 $0.001000 $0.08 $98.86 $49.43 0x $98.86 0.1%
To view Winx’s complete cap table history, request access »

Winx Patents

Winx Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
US-20150101615-A1 Systems, devices, and methods for retaining oral devices for airway treatment Inactive 11-Oct-2013 000000000
US-20150107603-A1 Reservoir antechamber for reducing foaming during saliva collection Inactive 07-Oct-2013 0000000000
US-20140360509-A1 Heating element for reducing foaming during saliva collection Inactive 06-Jun-2013
EP-2595584-A1 Airway device with tongue-engaging member Inactive 20-Jul-2010 000000000
EP-2595584-A4 Airway device with tongue-engaging member Inactive 20-Jul-2010 A61F5/566 0
To view Winx’s complete patent history, request access »

Winx Executive Team (11)

Name Title Board Seat Contact Info
Matthias Vaska Co-Founder, Chairman & Chief Executive Officer
Chris Daniel Co-Founder & Executive Vice President, Operations
David White MD Chief Medical Advisor
David Jones Chief Business Officer
Jonathan Podmore Co-Founder and Vice President, Research & Development
You’re viewing 5 of 11 executive team members. Get the full list »

Winx Board Members (7)

Name Representing Role Since
John Stevens MD Self Board Member 000 0000
Matthias Vaska Winx Co-Founder, Chairman & Chief Executive Officer 000 0000
You’re viewing 2 of 7 board members. Get the full list »

Winx Signals

Growth Rate

0.80% Weekly
Weekly Growth 0.80%, 93rd %
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers


Similarweb Unique Visitors


Majestic Referring Domains


PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial